槲皮素抗肝癌作用机制与临床研究进展OA
Research progress on mechanism of action and clinical applications of quercetin against hepatocellular carcinoma
肝癌是我国常见的消化系统恶性肿瘤,其发病率和病死率居高不下,目前肝癌的临床治疗面临术后复发率高、晚期患者耐药等问题,亟待开发新型防治策略和药物.传统中药具有多疗效、多靶点、多机制的独特优势,在抗肝癌治疗中应用已久,随着西药治疗肝癌的局限性不断显现,中药单体及其复方有效成分受到广泛关注,越来越多的研究表明中药黄酮类化合物具有显著的抗肝癌作用,天然黄酮类化合物槲皮素广泛存在于茵陈、虎杖、牡丹皮、车前子、白花蛇舌草、杜仲叶、银杏叶、桑叶等多种中药中,因其具有抗氧化、抗炎、免疫调节、保肝等多种药物活性及抗肿瘤作用而表现出独特优势和良好应用前景.该文围绕肝癌发生发展的关键分子网络与肿瘤微环境,全面梳理了槲皮素抗肝癌的作用机制,包含槲皮素对肝癌细胞增殖与凋亡、信号通路的调控,对肝癌细胞迁移与侵袭的抑制,以及对其代谢、微环境和耐药性等的调控作用,系统概述了槲皮素临床应用进展,以期为槲皮素在肝癌临床治疗中的应用提供理论依据,进一步优化其应用方案,为今后深入研究和临床应用提供相关依据.
Hepatocellular carcinoma,hereinafter referred to as liver cancer,is a prevalent malignant tumor of the digestive system in China,with persistently high incidence and mortality rates.Currently,clinical management of liver cancer faces significant challenges,including elevated postoperative recurrence rates and drug resistance in advanced-stage patients,underscoring an urgent demand for the development of novel preventive and therapeutic strategies and agents.TCM with its distinct advantages of multi-efficacy,multi-targeted action,and multi-mechanism effect,has long been employed in anti-hepatocellular carcinoma therapy.As the limitations of western medicine in liver cancer treatment become increasingly prominent,active components of TCM monomers and their compound formulas have garnered extensive attention.A growing body of research indicates that flavonoids from TCM possess notable anti-hepatocellular carcinoma effects.Quercetin,a natural flavonoid,is widely distributed in various TCM herbs,including Artemisiae Scopariae Herba,Ploygoni Cuspidati Rhizoma et Radlx,Moutan Cortex,Plantaginis Semen,Spreading Hedyotis Herba,Eucommiae Folium,Ginkgo Folium,and Mori Folium.Quercetin exhibits unique advantages and promising application prospects due to its diverse pharmacological activities,such as antioxidant,anti-inflammatory,immunomodulatory,hepatoprotective,and anti-tumor effects.Focusing on the key molecular networks and the tumor microenvironment involved in hepatocarcinogenesis and progression,this review comprehensively synthesized the mechanisms underlying the anti-hepatocellular carcinoma effects of quercetin,encompassing its regulation of hepatocellular carcinoma cell proliferation and apoptosis,modulation of signaling pathways,inhibition of cell migration and invasion,as well as its regulatory roles in tumor metabolism,the microenvironment,and drug resistance.Additionally,the progress in the clinical application of quercetin was systematically summarized.This review aims to provide a theoretical foundation for the utilization of quercetin in the clinical treatment of liver cancer,facilitate the optimization of its therapeutic regimens,and offer a relevant basis for future in-depth research and clinical translation.
梁锦晓;杨星;栗蕊;赵瑞霞;崔鸿雁;王雪寒;任蕤;姜中旗;邵明义
河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003河南中医药大学 第一附属医院 脾胃肝胆科,河南 郑州 450003||河南中医药大学 第一附属医院,河南 郑州 450003||河南中医药大学 第三附属医院,河南 郑州 450046
槲皮素肝癌作用机制黄酮类化合物协同作用
quercetinhepatocellular carcinomamechanism of actionflavonoid compoundsynergistic action
《中国中药杂志》 2026 (14)
3947-3954,8
国家自然科学基金项目(82474681)
评论